List of Figures
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
Proportion of Hyperphosphatemia In Chronic Kidney Disease to Nutritional Disorders Clinical Trials, G7 Countries (%), 2017* 16
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Hyperphosphatemia In Chronic Kidney Disease to Nutritional Disorders Clinical Trials, E7 Countries (%), 2017* 19
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 27
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30
GlobalData Methodology 81


List of Tables
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Region, 2017* 7
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
Proportion of Hyperphosphatemia In Chronic Kidney Disease to Nutritional Disorders Clinical Trials, G7 Countries (%), 2017* 16
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 17
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18
Proportion of Hyperphosphatemia In Chronic Kidney Disease to Nutritional Disorders Clinical Trials, E7 Countries (%), 2017* 19
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Phase, 2017* 22
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23
Hyperphosphatemia In Chronic Kidney Disease Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, by End Point Status, 2017* 25
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 26
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 27
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 28
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 29
Hyperphosphatemia In Chronic Kidney Disease Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 30